EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 339 filers reported holding EXELIXIS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,149,665 | +389.7% | 112,489 | +442.1% | 0.10% | +371.4% |
| Q3 2021 | $439,000 | -19.3% | 20,749 | -30.5% | 0.02% | -16.0% |
| Q2 2021 | $544,000 | -20.6% | 29,846 | -1.6% | 0.02% | -26.5% |
| Q1 2021 | $685,000 | -1.3% | 30,331 | -12.3% | 0.03% | -10.5% |
| Q4 2020 | $694,000 | -84.1% | 34,585 | -80.7% | 0.04% | -86.0% |
| Q3 2020 | $4,373,000 | +20.9% | 178,865 | +17.4% | 0.27% | +15.3% |
| Q2 2020 | $3,616,000 | – | 152,337 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |